Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 4

Status

Recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Rectal Neoplasms 4Colorectal Neoplasms 2Pathologic Complete Response 1Pancreatic Neoplasms 1

Interventions

Fluorouracil 61Leucovorin 56Oxaliplatin 51Capecitabine 42Irinotecan 29Bevacizumab 21Radiotherapy 17Cetuximab 12Folfox protocol 11Chemoradiotherapy 11Neoadjuvant Therapy 10Chemotherapy, Adjuvant 9Surgical Procedures, Operative 6Drug Therapy 6XELOX 5Panitumumab 4Laparoscopy 4FOLFOXIRI protocol 4Transanal Endoscopic Microsurgery 3Radiation 3Octreotide 3IFL protocol 3Floxuridine 3Diathermy 3Celecoxib 3vatalanib 2spartalizumab 2Trinitrotoluene 2Tegafur 2Semaxinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Rectal Neoplasms × FOLFOXIRI protocol × Clear all
NCT05081687 2023-10-11

BRAZIL-TNT

Hospital Israelita Albert Einstein

Phase 3 Unknown
150 enrolled
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT05201430 2022-03-04

RCNAC

Fudan University

Phase 3 Recruiting
300 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03975049 2019-06-05

Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 3 Not yet recruiting
933 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03671252 2019-01-23

Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation

Sun Yat-sen University

Phase 3 Recruiting
776 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡